Market closedNon-fractional
Tandem Diabetes Care/TNDM
13:30
15:10
16:45
18:25
20:00
1D1W1MYTD1YMAX
About Tandem Diabetes Care
Tandem Diabetes designs, manufactures, and markets durable insulin pumps for diabetes patients. The firm first entered this market in 2012 and has since introduced multiple generations of pumps leading to its current t:slim X2 device. The firm recently launched its smaller Mobi pump and continues to work on a tubeless pump. Nearly three-quarters of total revenue is derived from the us, with the remainder primarily from other developed nations. The pumps themselves generate just over half of total sales, and another one third is from disposable infusion sets that need to be changed over every 2 to 3 days.
Ticker
TNDM
Sector
Healthcare
Trading on
NASDAQ
Industry
Health Care Equipment and Supplies
Headquarters
San Diego, United States
Employees
2,400
Website
www.tandemdiabetes.com
TNDM Metrics
BasicAdvanced
$2.6B
Market cap
-
P/E ratio
-$2.17
EPS
1.29
Beta
-
Dividend rate
Price and volume
Market cap
$2.6B
Beta
1.29
Financial strength
Current ratio
3.81
Quick ratio
2.906
Long term debt to equity
189.345
Total debt to equity
196.47
Interest coverage (TTM)
-12.49%
Management effectiveness
Return on assets (TTM)
-9.70%
Return on equity (TTM)
-48.62%
Valuation
Price to revenue (TTM)
3.44
Price to book
10.73
Price to tangible book (TTM)
10.73
Price to free cash flow (TTM)
-39.706
Growth
Revenue change (TTM)
-3.11%
Earnings per share change (TTM)
-31.37%
3-year revenue growth (CAGR)
12.42%
3-year earnings per share growth (CAGR)
76.08%
What the Analysts think about TNDM
Analyst Ratings
Majority rating from 18 analysts.
TNDM Financial Performance
Income StatementBalance sheetCash Flow
Income Statement
Revenues and expenses
QuarterlyAnnual
Q1 24
QoQ growth
Revenue
$192M
-2.59%
Net income
-$43M
42.33%
Profit margin
-22.28%
46.10%
TNDM Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q2 23
Q3 23
Q4 23
Q1 24
Q2 24
Actual
-$0.30
-$0.38
-$0.27
-$0.63
-
Expected
-$0.53
-$0.34
-$0.25
-$0.76
-$0.54
Surprise
-43.60%
13.02%
6.01%
-16.85%
-
TNDM News
AllArticlesVideos
Tandem Mobi Improves Quality of Life for People Living With Type 1 Diabetes in New Data Shared at American Diabetes Association Scientific Sessions
Business Wire·1 month ago
Tandem Diabetes Care Appoints Jean-Claude Kyrillos as Chief Operating Officer
Business Wire·1 month ago
Tandem Diabetes Care to Present New Early User Insights on the Tandem Mobi System at the American Diabetes Association's 84th Scientific Sessions
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon
Market closedNon-fractional
Upcoming events
No upcoming events
FAQs
What’s the current market cap for Tandem Diabetes Care stock?
Tandem Diabetes Care (TNDM) has a market cap of $2.6B as of July 26, 2024.
What is the P/E ratio for Tandem Diabetes Care stock?
The price to earnings (P/E) ratio for Tandem Diabetes Care (TNDM) stock is 0 as of July 26, 2024.
Does Tandem Diabetes Care stock pay dividends?
No, Tandem Diabetes Care (TNDM) stock does not pay dividends to its shareholders as of July 26, 2024.
When is the next Tandem Diabetes Care dividend payment date?
Tandem Diabetes Care (TNDM) stock does not pay dividends to its shareholders.
What is the beta indicator for Tandem Diabetes Care?
Tandem Diabetes Care (TNDM) has a beta rating of 1.29. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.
Buy or sell Tandem Diabetes Care stock
Stocks, funds and up to 4.50% interest earned on uninvested cash. When you invest, your capital is at risk.